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General Abstracts
Chapter 1
Mycobacterium avium complex (MAC) has become one of the major problems in public
health and livestock. Members of MAC, such as M. avium subsp paratuberculosis (MAP) and M.
avium subsp hominissuis (MAH), are responsible for many opportunistic infections and the loss
of livestock. MAP is economically significant to the beef and dairy industries because it is the
etiologic agent of Johnes’s disease, a chronic and fatal enteritis in ruminants. Tracing the
infection sources of MAC could be difficult since it infects many types of hosts in the natural
environment. Furthermore, there is less information known about MAP pathogenicity in specific
hosts, but some strains often predominate in certain hosts. Being able to differentiate subspecies
of MAC, as well as to trace MAP host species of origin, would be important tools for researchers
to assess the potential pathogenicity, transmissibility, and environmental persistence of the
strains to limit outbreaks. Thus, this study aimed to characterize M. avium subspecies and to
identify MAP host species of origin using MALDI TOF MS (Matrix Assisted Laser
Desorption/Ionization- Time of Flight Mass Spectrometry) library and FT-IR (Fourier
Transform-Infrared Spectroscopy) biomarker based proteomic approaches. MALDI-TOF MS
provided more sensitive characterization of MAC subspecies through matching mass fingerprint
of isolates with a custom main consensus library (MSP). The manufacturer’s database (BDAL)
discriminated 14 out of 47 MAC isolates (29 %). Our new data database (MSP) could identify
80% of the total isolates (40/47). Our Kappa Analysis was 0.73, signifying good agreement
between the PCR and MALDI-TOF results. The FT-IR offered visualization of unique IR spectra
that could be analyzed based on the cell wall components present in the cell, such as mycolic
acid and peptidoglycan. Both instruments could successfully classify each subspecies of MAC,
but it failed to track the host origin of species of MAC.
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Chapter 2
Porcine reproductive and respiratory syndrome (PRRS) is a major viral disease
responsible for huge economic losses and morbidity in the swine industry. Clinical signs of
PRRS include chronic respiratory disease among young pigs and reproductive failure of pregnant
sows. The etiologic agent of PRRS is a member of Arterivirus, and known as PRRS virus
(PRRSV). There are two types of PRRSV circulating worldwide, classified as PRRSV-1
(European) and PRRSV-2 (North American). Genetic variations among PRRSVs are common as
their RNA genome is prone to mutation. Multiple types of vaccines have been created, including
a synthetic vaccine candidate (PRRSV-CON) which can provide broader protection against the
two types of PRRSV (Vu et al., 2015). Nevertheless, the mechanism of how PRRSV provides
immune protection remains unclear regarding which viral proteins trigger optimum immune
responses. Hence, in this project, our goal was to determine the relative contribution of PRRSV2 structural proteins located in Open Reading Frames (ORFs) 2-7 to immune responses. We used
PRRSV-1 as a backbone for our construct and inserted PRRSV-2 structural proteins. Our
construct was not successfully recovered in the cell culture, possibly because the replacement of
ORF2-7 from a divergent genotype may interfere with viral replication.
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A. Chapter 1
1. Background and Literature Review
1.1 Characteristics of Mycobacterium avium complex (MAC)
1.1.1 Taxonomy and Phylogenetics
Mycobacterium avium complex (MAC) is a part of genus Mycobacterium in the family of
Mycobacteriaceae. MAC is a group of organisms consisting of two major species:
Mycobacterium avium and Mycobacterium intracellulare. M. avium is further categorized into
four subspecies: M. avium subsp. paratuberculosis (MAP), M. avium subsp. hominissuis (MAH),
M. avium subsp. silvaticum (MAS), M. avium subsp. avium (MAA), as is shown in Figure 1
(Biet et al., 2005). The classification of these subspecies is based on whole genome sequence
analysis of 16s and 23s ribosomal RNA internal transcribed spacer (ITS) (Mijs et al., 2002).
Furthermore, the subspecies classification is also dependent on the host range. Each of the M.
avium subspecies often predominates certain hosts; for instance, MAP and MAH are often
isolated in swine and humans, while the other two subspecies are commonly found in birds
(Rathnaiah et al., 2017). The genetic diversity of MAC is high, which was confirmed in a study
from Arbeit et al finding that there were 10 different serovars of MAC found in samples from
AIDS patients. Likewise, analysis of restriction fragment length polymorphisms (RFLP)
provided different genetics sequence patterns between MAC strains in AIDS and non-AIDS
patients (Arbeit et al., 1993). Internal multidrug resistance genes for MAC are known to be pks
12 and maa 2520. Pks 12 is a gene related to cell permeability and maa 2520 is associated with
cell surface proteins. The presence of these two genes in MAC will increase resistance toward
drugs such as ciprofloxacin, clarithromycin, and penicillin by inhibiting drug penetration into the
cells (Philalay et al., 2004).
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Phylogenetics of MAC (Biet et al., 2005)

1.1.2

Physical Characteristics

MAC members are gram positive, acid-fast, and facultative intracellular aerobes. These
bacteria are small, non-motile rod shapes, and non-spore forming, with a size of (0.5 × 1.5 μm).
MAC is also characterized by slow-growing bacteria with a generation time of 20 hours The cell
walls of MAC have a lipid content of 60%, creating a highly hydrophobic environment with low
permeability. Most of the lipid makes up the mycolate portions. The peptidoglycan portions are
bounded by arabinogalactan, which is the integral part of cell wall formation. The synthesis of
MAC cell walls, particularly MAP, is complex and dependent on the essential growth factors.
Initial attempts to grow MAP in vitro initially failed because growth requires mycobactin J, an
iron-binding siderophore. This occurred because MAP has lost its mbtA gene in the mycobactin
synthesis operon(Biet et al., 2005).
1.1.3

Virulence Factors

Most members of MAC are opportunistic pathogens with several virulence factors. One
key virulence factor of MAC is lipoarabinomannan (LAM) located in the outer surface of the
cells. LAM suppresses immune responses by inhibiting IFN-γ induction and cytokines of
macrophages. The mycolic acid of MAC is immunogenic and toxic in mammalian cells. These
characteristic features facilitate MAC survival in unfavorable conditions and the presence of
antibiotics(Philalay et al., 2004). In general, the virulence factors of MAC are due to the
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organisms’ ability to survive inside macrophages. MAC resists the acidification of macrophages
and inhibits Rab7 protein, which is important for fusion of phagosome and lysosome.
Furthermore, a study from Li et al, suggests that PPE and PE gene families, encoding for
numerous unknown proteins, contribute to the virulence of MAC, as mutants of these genes can’t
prevent the fusion of lysosomes and phagosomes in macrophages (Li et al., 2010).
1.1.4 Pathogenesis of MAC
The survival strategy of MAC is based on their ability to escape from the host defense.
MAC activates mitogen-activated protein kinase (MAPK) pathway to upregulate interleukin 10
(IL-10). As a result, increased IL-10 blocks phagosome maturation. Thus, MAC can maintain
survive inside the host cells (Hussain et al., 2016). High concentration of IFN-γ and granulocyte
macrophage-colony stimulating factor can also inhibit intracellular growth of MAC in the bovine
monocytes (Rathnaiah et al., 2017). In addition, in a complimentary experiment by Rathnaiah et
al, murine macrophage cell lines treated with high level of TNF-α produced lower recovery of
viable MAC.
The pathogenesis of MAC is likely influenced by nutritional status in animals. An
experiment with mice showed a reduced amount of dietary calcium could suppress MAC
infection (Rathnaiah et al., 2017). Iron availability is also a significant factor since it is required
for the cytochromes to transport electrons, and it is involved in oxygen metabolism of other
hemoproteins, such as catalase-peroxidase KatG (de Voss et al., 1999). The majority of MAC
hosts restrict the ability of MAC to harvest iron. In an activated macrophage, transferrin
receptors are downregulated to limit the concentration of free iron (Wang et al., 2015). To
overcome this, most of the mycobacterial species produce lipid-soluble mycobactin and water
soluble siderophore exochelin (Rathnaiah et al., 2017). These features are significant in the
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virulence factors of MAC to enable iron acquisition. Interestingly, MAP only produces
exochelin, and little is known about how it survives without mycobactin.
1.2 Epidemiology
1.2.1 Transmission of MAC
The exposure of MAC to humans can come from various routes. This includes natural
biotopes like insects and protozoa or contaminated food and shedding. Birds are the major agent
of transmission as they can transmit MAC through feces for broader distances (Rathnaiah et al.,
2017). Once MAC contaminates soil and environment, it is difficult to eliminate as it can persist
for long periods of time. Thus, most of the transmission in ruminants and livestock is due to fecal
contamination of MAP from wildlife and environment (Biet et al., 2005).
1.2.2 Variable Genetic Elements
MAC members are diverse and are difficult to differentiate. However, molecular
epidemiology with RFLP is able to differentiate members of MAC from different hosts
(Rebuffo-Scheer et al., 2007). It is suspected that the strains may undergo adaptation. A study
using RFLP analysis found MAP in sheep and MAP in cattle are distinct(Roiz et al., 1995).
Moreover, insertion sequences that are specific to MAC are often used for epidemiological
analysis. Insertion sequences are a mobile genetic element, having transposition function. The
family of MAC insertion sequences have a specific feature of lacking both terminal inverted
repeats in their insertion sequences (IS). There are four IS found belonging to MAC: IS 900 for
MAP, IS 901 MAA, IS 902, MAS, IS 1110 for MAA and MAI (Kunze et al., 1992).
1.2.3 Host Ranges
The host ranges of MAC are diverse in the environment and wildlife due to their
flexibility to adapt in various conditions. Birds and ruminants are the most common reservoirs
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harboring MAC. Interestingly, MAC also infects insect and protozoa (Biet et al., 2005). Little is
known about how MAC dominates in a certain host. Nevertheless, host adaptation can change
the microbial morphology. The fatty acid (FA) profiles between MAP infecting sheep are
different from MAP infecting cattle. This implies that FA composition may affect the survival of
MAP in different host macrophages (Alonso-Hearn et al., 2017).
1.3 Clinical Diseases, Treatments, Impacts
1.3.1 Clinical Diseases
Johne’s disease causes a severe chronic enteritis, primarily caused by MAP, a member of
MAC. It is highly contagious among ruminants, and the transmission of the pathogen often goes
unnoticed until the clinical signs develop well after exposure and initial infection. In the US,
dairy herds have been reported to have very high prevalence of Johne’s disease. It could
approach to 100 % herd level prevalence among large herds (McNees et al., 2015). The clinical
signs of Johne’s disease in cattle include diarrhea and weight loss with normal appetite. After the
establishment of diarrhea, the cattle will develop “bottle jaw.” This occurs because proteins are
lost from bloodstream to the digestive tract (protein losing enteropathy). As a result, it will cause
edema in its jaw due lowered oncotic pressure within blood plasma. At this stage, the survival
rate is very low, and the infection may have spread widely in the herd. For sheep and goats, the
clinical signs are even harder to notice. Usually, the infected sheep will have normal appetite, but
it loses a lot of weight because the intestine fails to absorb nutrients. However, diarrhea is rarely
observed in sheep in contrast to cattle. As the clinical diseases progress, the shedding increases.
Thus, it enhances the risk of transmission.
MAP is also suspected to have association with an inflammatory bowel disease,
commonly called Crohn’s disease (CD) in humans (McNees et al., 2015). Crohn’s disease is
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parallel to Johne’s disease as it affects digestive system. The signs and symptoms of Crohn’s
disease in humans are abdominal pain, diarrhea, and blood in the stool It was thought that
Crohn’s disease was an autoimmune disease. Several attempts to culture MAP was unsuccessful
until Naser et al did culture MAP. His study suggests that MAP contributes to Crohn’s disease.
Furthermore, PCR tests of Crohn’s disease patients show positive results of MAP DNA. This
result together with Meta-analysis data confirmed the present of MAP DNA in Crohn’s disease
patients. Hence, there is a strong linkage between MAP and Crohn Disease (Naser et al., 2014).
1.3.2 Economic Impacts
In the United States, the economic impacts of Johne’s disease are significant to the dairy
and beef industries. The losses are mostly attributed due to reduced milk production, premature
culling, and weight loss at slaughter. For Johne’s-positive herds, the industry could lose
approximately $100 per head (Ott et al., 1999). The production of milk can be reduced up to 700
kg/head for high-prevalence herds. Several reports have estimated the annual loss due to Johne’s
disease in regions, such as in New England at $15.4 million, $54 million in Wisconsin, $5.4
million in Pennsylvania, and $200 million to up to $250 million loss annually throughout the US.
In comparison, in Australia, the loss is estimated to be $2.1 million (Garcia & Shalloo, 2015).
1.3.3 Treatments
Since there are no clinical signs observed in the initial infection of MAP, it is very hard to
control MAP transmission. Hence, early detection of MAP is the best practice to prevent Johne’s
disease (JD). Treatments for JD are mostly ineffective as the majority of MAP are resistant to
therapy (Philalay et al., 2004). Vaccines are currently available, but they are limited and do not
give long term protection against JD. For instance, a licensed vaccine, Mycopar, is produced
from protein derived MAA strains. Thus, it does not give optimum responses against MAP or
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other MAC variants (Bastida & Juste, 2011). Moreover, In Australia, heat-killed vaccine made
from MAP 316F strains could provide better immunity, but the vaccine compromises JD
diagnosis tests, make it difficult to detect between vaccinated and unvaccinated animals
(Mancini et al., 2013).
JD treatments with antibiotics could be effective, but it is never encouraged for economic
reasons because it is highly unlikely the animals can be cured, and the cost of the antibiotic is
expensive. In addition, the consequences of long-term antibiotic treatment may affect the
production of milk and meat, and it may not pass the USDA regulations as the drug may not be
proper for human consumption (Philalay et al., 2004). It has been demonstrated that macrolide
drugs, such as clarithromycin and azithromycin, have potent efficacy in vitro, while antituberculosis and anti-leprosy drugs are not effective against MAP with exception of rifampicin
family (Krishnan et al., 2009). These results do not correspond to the in vivo results. When the
drugs were tested in cattle infected with MAP. There was only 50% of success rate with
antibiotic treatments. Hence, antibiotic therapy is not the best way to treat JD (Krishnan et al.,
2009).
1.4 Diagnostic Tests
Various diagnostic tests have been developed for early detection of MAP. The most common
diagnostic tests include Polymerase Chain Reaction (PCR), isolation of MAP by culture, and
direct acid-fast staining of clinical samples. Usually the initial screening of MAP is done with
acid-fast staining because it is fast, simple, and cheap. However, due to lack of specificity,
further screening by PCR or immunoassay is needed to confirm the specificity of MAP. The
“gold standard” for JD diagnosis is isolation of MAP culture in lab. Since it is known that MAP
is dependent on the presence of mycobactin, it is very easy to distinguish between those MAP
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and non-MAP in the media lacking mycobactin. However, this method is not practical in terms
of the lengthy process to grow the culture for 6-8 weeks (Krishnan et al., 2009). PCR assay
provides more a rapid and sensitive diagnosis. The assay uses primer IS900, an insertion element
that is specific to MAP, but a study suggests that it may give false positive results as the insertion
element is also present in other species of mycobacteria(Erume et al., 2001).
1.4.1 Matrix Assisted Laser Desorption ionization-time of flight mass
spectrometry (MALDI-TOF MS)
Current emerging technologies have been able to differentiate MAC and detect MAP in
rapid and cost-efficient ways (Singhal et al., 2015). MALDI-TOF Biotyper is one example of a
technology platform developed in Germany by Bruker Daltonik to characterize and compare
mass fingerprints from microbiological samples. This instrument uses an analytical method of
mass spectrometry where the samples are crystallized and ionized into charged ions, and their
mass to charge ratios are measured. Unlike the regular mass spectrometry in the chemical
sciences, MALDI-TOF Biotyper utilizes matrix assisted laser desorption ionization (MALDI) to
detect larger molecules like proteins. Peptides are ionized by the addition or loss of one or more
protons. Thus, this soft ionization will not cause huge loss in the sample integrity. One major
advantage of MALDI-TOF MS is that it does not require sample separation by chromatography,
and the samples can be applied directly for MALDI-TOF analysis. In addition, it also produces
single charged ions, providing easier interpretation for the samples results.
The principle of MALDI-TOF MS is similar to regular mass spectrometry with an
exception to the preparation methods. The samples for MALDI-TOF MS require an energy
absorbent reagent from organic compound called matrix to coat the samples. This matrix will
crystallize the sample after drying, and it will trap the analyte inside the crystal (Singhal et al.,
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2015). The crystallized matrix will be ionized by a laser beam. A single ion from analytes of the
samples will be generated. Then, the protonated ions will move at fixed potential, where they
separate based on their mass to charge ratio (m/z). The mass analyzer and TOF (time of flight)
analyzer will detect the movement of protonated ions. The m/z ratio will be measured based on
the time required for the protonated ions to move to the length of the flight tubes. Some TOF
analyzers have an ion mirror at the rear end of the flight tubes. The function of this feature is to
correct small differences in energy among ions by reflecting the ions from the flight tubes to the
detector. The MALDI-TOF device work in tandem with computer software to do analysis that
will display characterized spectra called peptide mass fingerprint (PMF) from analytes of the
samples (Croxatto et al., 2012a).
To identify microbes, the PMF of the unknown microbes will be matched with the PMFs
of microbes stored in databases, or another option is to match the PMF of unknown microbes
with a proteomic database (Murray, 2012). Identification of microbes at the species level is
driven mainly by the detection of highly abundant ribosomal proteins and some housekeeping
proteins with typical mass range of 2-20 kDa.
There are several sample preparation methods that have been developed for MALDI-TOF
Biotyper analysis, and these may depend on the nature of the microbes. Some microbes may
require more complicated sample preparations to ensure adequate peptide liberalization and
ionization. The easiest and fastest method is the direct smear method, in which a colony of
bacteria is collected and spotted onto MALDI target plate with a sterilized toothpick and left to
dry for few minutes before coating it with the matrix. HCCA (α-cyano-4-hydroxycinnamic acid),
2,5-dihydroxy benzoic acid (DHB), and 3,5-dimethoxy-4-hydroxycinnamic acid (sinapinic acid)
are matrices commonly used for microbiological samples as they have been proven to be the
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most efficient (de Alegría Puig et al., 2017). These matrices contain water and organic solvents,
such as ethanol, acetonitrile, or trifluoro acetic acid (TFA), which help to dissolve the cell wall
of microbes and extract the intracellular components. As the solvent dries, the matrices will cocrystallize with the intracellular components. For complex microorganisms, an extra preparatory
extraction is required to maximize the PMF generation. Addition of formic acid could increase
the PMF quality of Gram-positive bacteria, but not in Gram-negative bacteria (Alatoom et al.,
2011). For mycobacteria, heat killing in 95° Celsius heat bath and longer vortexing with zirconia
silica bead are necessary to lyse and extract the intracellular protein as these bacteria have waxy
layers (Saleeb et al., 2011).
It has been reported that the culture conditions do not affect microbial identification by
MALDI-TOF MS although it changes microbial physiology and the protein expression.
Carbonelle et al cultured distinct condition with distinct culture time, and it did not influence the
result of MALDI-TOF identification (Carbonnelle et al., 2007).
Application of MALDI-TOF is not limited to detection of bacteria. It can identify a broad
range of microorganisms such as viruses and fungi, and it can also detect antimicrobial resistance
phenotypes. Croxatto et al. reported that MALDI-TOF MS could discriminate S. aureus with
methicillin resistance (Croxatto et al., 2012a). There is a shift in the PMF for resistant microbes.
For instance, in β-lactam resistant bacteria, the bacteria produce the enzyme β-lactamase to
hydrolyze β-lactams. This can be detected by MALDI-TOF MS with a specific assay called
“mass spectrometric β-lactamase (MSBL) assay.” To prepare this assay, both antibiotic and the
bacteria are mixed in the culture and incubated. Afterwards, the mixture is centrifuged, and the
supernatant is taken for MALDI-TOF MS analysis. The PMF generated will shift from nonhydrolyzed to hydrolyzed form of β-lactam. Hence, it can identify the presence or absence of β-
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lactam resistant bacteria (Hooff et al., 2012). Another study supports the ability of MALDI-TOF
MS to detect the activity of carbapenemase of enteric bacteria and pseudomonas (Croxatto et al.,
2012a).
Application of MALDI-TOF in virology is quite distinct from the work in bacteriology.
The analysis is of samples is challenging due to low protein expression in most of the viruses.
PCR amplification is often required before MALDI-TOF analysis for viruses (Sjöholm et al.,
2008). In mycology, the ascomycetous and basidiomycetous yeasts have been reported to have
high quality of PMF profiles, while other families of fungi are still difficult to extract due it their
biological complexity and co-existence with different fungal phenotypes. Thus, MALDI-TOF
may not be the best option for fungal identification (Santos et al., 2010).
1.4.2 Fourier Transform -Infrared Spectroscopy (FT-IR)
Fourier Transform-Infrared Spectroscopy is another emerging technology that could provide
a fast method to identify microorganisms. Similar to MALDI-TOF MS, FT-IR produces spectral
fingerprints that are unique for various species of bacterial strains. The basis of FT-IR analysis is
on the measurement of infrared region of the electromagnetic radiation spectra. IR spectra are
formed due to the absorption of energy released by the molecular bond that undergoes
vibrational excitation. Each molecule, like proteins in the sample, has different bonds that absorb
energy at different frequencies. Hence, it should be expected that the patterns of various bacterial
species must be distinct (Rodriguez-Saona et al., 2001). A technique called attenuated total
reflectance (ATR) is integrated into FT-IR system. ATR technique enables the instrument to
collect IR radiation reflected from the surface of viscous and thick samples (Ojeda & Dittrich,
2012).
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Bruker Daltonik developed FT-IR Biotyper (Biotyper-IR) specific for bacterial identification
with a spectroscopy system focusing on the vibration of carbohydrate constituents such as
glycoproteins (Rodriguez-Saona et al., 2001). The bacterial cell surface is the key analyte, which
allows FT-IR to detect and differentiate various bacterial species. For example, the cell surface
between Gram-negative and Gram-positive bacteria are distinct from each other. Gram-negatives
have a low amount of peptidoglycan and a high amount of lipopolysaccharides (LPS), whereas
Gram-positive bacteria are composed of mostly peptidoglycan with lipoteichoic acids. Some
bacteria might have capsules, flagella, fimbriae, glycolates, lectins, and mycolic acids—all of
these distinct properties of cell surface produce wide variety of IR spectra. Thus, comparison of
two IR spectra from different organisms could be performed easily (Rodriguez-Saona et al.,
2001).
The sample preparation for FT-IR varies depending on the bacterial species. For
mycobacteria, Scheer et al. suspended a liquid colony of mycobacteria, pre-treated it with warm
water, and diluted the sample before inoculating it in the agar plate. This method produces a
consistent amount of colony to produce good quality IR spectral (Rebuffo Scheer et al.,2017).
Bosch et al. prepared sample for Gram-negative bacteria by harvesting a loopful of sample and
suspending it with distilled water. Afterwards, he aliquoted the bacterial suspension in the optical
plates and left it to dry. The formation of thin bacterial film could be seen from the plates (Bosch
et al., 2008).
There are several types of analysis used for FT-IR. Analysis such as Principle Component
Analysis (PCA) and Soft Independent Modeling of Class Analogy (SIMCA) are commonly used
for bacterial identification. The basic theory of FT-IR is based on the absorbance of the
functional group present in the samples. The absorbance values will then be calculated by PCA
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or SIMCA algorithm. PCA directs data into linearly uncorrelated variables and organizes the
data based on variance within the data. SIMCA utilizes a distinct PCA model for each class of
variables.
Since FT-IR is quite new technology, the evaluation and application of this technology is
still limited to some bacterial species such as Enterobacteriaceae, Staphylococcus, Aeromonas,
Pseudomonas, and Cyanobacteria. FT-IR can discriminate different bacteria taxa down to the
strain level (Rodriguez-Saona et al., 2001). The application of FT-IR in virology is possible for
detection and viral quantification. Montiel et al. grew cell culture as biosensor in the ZnSe
crystal, and he transfected the poliovirus in the cell culture for FT-IR analysis. Non-infected and
infected cells produced distinct IR profiles (Lee-Montiel et al., 2011). FT-IR can also
characterize fungi from food spoilage down to species level (V Shapaval et al., 2013).
Furthermore, Grunert et al. attempted to serotype the capsule of S. aureus with FT-IR assisted
artificial neural networks (ANN) analysis. Both external and internal validations of S. aureus
capsular typing value show promising results of 96.7% and 98.2% (Grunert et al., 2013).
1.4.3 Serological Tests
Detection for MAC, particularly MAP, could be done indirectly by enzyme-linked
immunosorbent assay (ELISA). As it is mentioned before, the infection of MAP induces Thelper cells to produce IFN-γ. The changes in IFN-γ level can be measured in an ELISA. In this
study, one day old blood culture supernatants are taken from cattle that has been stimulated with
Johnin—a purified protein derivatives from MAP—and bovine IL-12 (Jungersen et al., 2012).
However, this test is not effective as it is reported there is cross-reactivity between Johnin protein
and IFN-γ. Another alternative could be using lipopeptide L5P, which is the cell wall of MAP. A
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study used this antigen for the ELISA assay, but the results showed lower value as compared to
the one with Johnin proteins (Jungersen et al., 2012) .
1.4.4 Real Time PCR
The most common diagnostic test with PCR uses IS900 as the target, but as mentioned
before, this target gives false positive results (Erume et al., 2001). New target sequences specific
for MAP have been identified. Sequences such as ISMAP02 present in MAP in multiple copies.
This target combined with IS900 could improve real time PCR sensitivity (Park et al., 2016). A
study from Shin et al. with five targeted multiplex PCR could significantly detect different
members of MAC. A chromosomal target DT1, which is specific for MAA, MAS, and MAI
along with IS900, IS901, and IS1311 are the targets for multiplex PCR. 53 MAC reference
strains consisting of 28 different mycobacteria strains were tested to evaluate the identification
accuracy for this method. There was 100% agreement between MAC multiplex with isolates.
Hence, this novel method could be one of best potential for MAC detection and identification
(Shin et al., 2010).

2. Matrix Assisted Laser Desorption/Ionization Time-of-Flight Mass
Spectrometry (MALDI-TOF) Project
2.1 Introduction
Over the past few decades, infections due Mycobacterium avium complex (MAC) have
become a major problem in livestock industries and contribute to large economic losses and
morbidity of livestock. Two clinically important subspecies of M. avium are M. avium subsp
paratuberculosis (MAP) and M. avium subsp hominissuis (MAH). MAP is the etiologic agent of
Johne’s disease, a chronic and fatal enteritis in ruminants that has been linked to Crohn’s disease
in humans. MAH has zoonotic potential as it is one of the leading causes of secondary infections
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in AIDS patients. Identification of M. avium subspecies is still challenging because the strains
have overlapping host ranges and clinical signs. Information about the host specificity of M.
avium also has not been determined. Therefore, tracing the infection sources to reduce the
transmission is difficult. Currently, common diagnostic tests for M. avium, such as blood and
biochemical tests, are labor intensive, time consuming, and, in certain cases, unreliable.
Advanced diagnostic tools, namely matrix-assisted laser desorption ionization time-of-flight
mass spectrometry (MALDI-TOF MS), could provide a rapid, low-cost, and accurate diagnostic
test to differentiate MAP. This test could be implemented into diagnostic workflows in
veterinary diagnostic labs, where this technology is often already in use. The purpose of this
project is to differentiate M. avium subspecies from field isolates (particularly MAP and MAH),
distinguish these isolates from other members of the M. avium complex (MAC), and determine
the host species of origin using MALDI TOF MS library and biomarker based proteomic
approaches.
2.2 Materials and Methods
Bacterial strains: A total of 57 bacterial isolates that include 33 MAP isolates, 22 non-MAP
isolates, and 2 ATCC references strains were used in this project. The field isolates were
previously identified with morphological and genomic approaches by PCR at Dr.Collins’ lab at
UW-Madison, Dr.Barletta’s lab at UNL, or were acquired from ATCC. The species of the
isolates comprised of M. avium ssp paratuberculosis, M avium ssp hominisuis, M.intracellulare,
M avium ssp avium, M avium ssp silvaticum, and non-tuberculous mycobacteria. All the strains
were isolated from various hosts from different states within the United States.
MALDI-TOF Sample Preparation: After preliminary work examining different extraction
protocols, the heat inactivation and extraction method for Mycobacteria sp recommended by the
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manufacturer was utilized in this project. Biomass of mycobacteria was collected (approximately
one to two 10µL inoculation loops) from solid media and suspended in 300µL deionized water.
Heat inactivation was accomplished in the thermoblock with 98°C temperature, followed 900µL
EtOH addition, and centrifuged for 2 minutes. The supernatant was removed completely, and the
pelleted cells were resuspended in 500 µL deionized water and centrifuged. Next, the cell lysates
were subjected to formic acid and acetonitrile extraction procedures and vortexing. In addition,
to break the cell wall of mycobacteria, the bead beating using 0.5 mm zirconia-silica bead were
applied (during vortexing) to get the intracellular protein of the cells. The extracted samples were
spotted each 1 µL on the MALDI target plate together with HCCA matrix (a-cyano-4hydroxycinnamic acid) and incubated to dry. Analysis process to generate spectral profiles were
done by manufacturer’s software (Bruker Biotyper).

Figure 1: The Schematic of MALDI-TOF Heat Inactivation Methods
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2.3 Results
MALDI-TOF MS Analysis: fourty-seven out of 57 isolates were able to generate valid
spectral profiles. Comparative evaluation between these isolates and reference spectral profiles
from Bruker Daltonics (BDAL) database exhibited average log score values of <2.0 as shown in
the Table 1. Only 14 isolates had log score values higher or equal to 1.6, which is the minimum
standard value for identification. Thus, the BDAL database only can appropriately classify 29 %
(14/47) of M. avium. In contrast, most of the isolates that were matched against the custom main
consensus library (MSP) generated from M. avium isolates displayed a much higher log score
with values of >2.0. This new library could accurately identify 85% (40/47) of M. avium at the
species level, which significantly improved identification accuracy. Furthermore, MALDI-TOF
MS was able to characterize M. avium at subspecies level as it is shown in Figure 1. The
dendrogram shows clusters of non-MAP strains and MAP strains that agree with the PCR results
from Dr.Collins’ lab. In Figure 4, two major clusters of MAP were identified. The bottom cluster
of MAP is more closely related to MAH, while the top cluster of MAP does not have relation to
MAH. Non-tuberculous mycobacteria and M. intracellulare have the furthest distance, which
corresponds to less overall genetic relatedness to MAP as both are not a member of M. avium.
Interestingly, two reference strains, M. avium silvaticum (ATCC 49884) and M. avium avium
(ATCC 25291), do not cluster together although both strains have similar host ranges in avian
and pigeon.
MALDI-TOF Kappa Analysis: Cohen’s Kappa Analysis was calculated using JMP 15 Pro
(SAS Institute Cary, NC) software to verify the agreement (K value) between top match score
subspecies and the multiplex PCR-ID subspecies in Table 1. If the top match score subspecies
was similar to the subspecies from PCR-ID and the score was above 2, it was indicated as “1” or
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agreement in the Kappa analysis, and “0” if it does not match or had lower values. There were
6/45 isolates having “0” Kappa analysis and the rest of the isolates (39/45) indicating “1” Kappa
analysis. The K-value for the MSP database was found to be 0.73, portraying overall “good”
levels of agreement (Table 2 and 3).
2.4 Discussion
Prevention and early diagnosis of MAP is critical since it causes significant economic
lost in the dairy industry, along with its correlation to Crohn’s Disease in humans. Tracing and
characterizing the sources of the disease with a rapid, high accuracy instrument would be
beneficial over traditional methods. Multiplex PCR method remain the “gold standard” for
molecular typing down to subspecies level, even though it has several drawbacks, such relative
high cost, labor intensive, and time consuming. This may not be advantageous in clinical lab
settings. Furthermore, the multiplex PCR methods require primers designed to target sequences
specific to the subspecies for DNA amplification in the PCR. The method is more complicated
for the present application since subspecies members of MAC have multiple unique target
sequences. For instance, in M. avium ssp avium, specific probes must be made to target
chromosomes, named DT1. Moreover, two others in MAC—M. avium silvaticum and M.
intracellulare –need three probes to target insertion sequences of IS 900, IS 901, IS 1311(Mijs et
al., 2002). The research described here and from the aforementioned study suggest MALDI-TOF
could be a potential tool for rapid diagnosis of MAP in the clinical setting(Croxatto et al.,
2012a). By creating MSP for all members of MAC, the accuracy of MALDI-TOF to identify
subspecies of MAP could improve further. Figure 2 and 3 portray comparison between top
match scores of BDAL and MSP. The BDAL provides lower value (1.45) than the MSP (2.7).
BDAL database collections are comprised of various isolates of bacterial species, which is not

A n t o n i k a | 25

specific for MAP. There are only four mycobacteria fingerprints in this database and only one
being MAP (ATCC 19698). This could be the reason BDAL provides a lower top match score,
as the software algorithm could not recognize a similar pattern to the one MAP representative,
indicating a higher level of strain diversity that is not represented in the current database. The
new MSP database provides a fingerprint collection specific for MAC members. Thus, the
algorithm could detect the MAP fingerprint pattern more accurately. For MAP isolates, the
BDAL database could only give an 18% level of good match scores in total, while the MSP
provided 93%. This indicates a 75% increase in matching accuracy. For non-MAP, the matching
accuracy only enhances 47%. It remains unclear what factors are involved in reduced matching
accuracy for non-MAP, but contaminated samples could be one factor, as we did not administer
antibiotic in the 7H9 media. It has been observed that non-MAP can be easily contaminated with
other bacterial species because its colony morphology could be similar to commensals, having
slimy and wetter colonies than MAP. Overall, since the Kappa analysis yield good agreement
after the creation of new MSP, the application of MAP diagnosis with MALDI-TOF is possible
as an alternative over PCR methods.
Despite the advantages of MALDI-TOF for MAP diagnosis, the limitations are in the
sample preparation. It requires long incubation time to grow both non-MAP and MAP. NonMAP requires almost one-week incubation, while MAP takes three weeks to four weeks. Cell
extraction for MAP is complex and it is time consuming some for vortexing with zirconia silica
beads. The concentration of formic acid and acetonitrile could affect the extraction process.
Better spectral profiles are generated when cell lysates are more concentrated with these
reagents. Yet, reducing the amount of reagent could increase noise and result in insufficient cell
lysates for replicates. Some studies suggested the quality of spectral profiles depends on the
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sample preparation. Thus, sample with some unextracted cells or non-homogenized cells could
result in distinct spectral profiles. During this research process, some MAP isolates were difficult
to grow and had a lot of noise signal. Second attempts to extract these MAP isolates were done,
but the cell lysates could not be processed homogenously due to the dry and waxy nature of the
MAP colonies. This has complicated the result in the dendrogram shown in the Figure 4. We
expected that there would only be two large clusters of MAP and non-MAP. However, it
displays otherwise in Figure 4.
The result of dendrogram (Figure 4), displays interesting potential relationships between
members of MAC. M. intracellulare and non-mycobacteria were expected to have their own
cluster since they are phylogenetically distinct from other subspecies of MAC (shown in the
phylogenetic figure). Both M. avium silvaticum and M. avium avium are known to predominate
birds, yet in the dendrogram, M. avium avium is more closely related to M. hominissuis than to
M. silvaticum. Apparently, M. hominissuis was named after M. avium avium which had adapted
to mammalian hosts. Thus, they have shorter genetic distance (Mijs et al., 2002).
2.5 Conclusion
To conclude, MALDI-TOF MS could be a good alternative tool for a diagnostic test to
rapidly characterize and identify M. avium. The new library database that was created in this
project could significantly enhance the sensitivity of the instrument as it increases the matching
score values using well characterized isolates. Over 85% of the isolates could be classified
correctly using our new MSP database, whereas the current BDAL database could only
characterize the isolates in 29% of cases. Although there were seven isolates that failed to have a
higher score value when using our MSP database, their top match values were still greater as
compared to the BDAL database score. Therefore, we consider that our new MSP database is a
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large improvement over the previous database. Our MSP dendrogram (Figure 4 exhibited
accurate characterization, which shows a potential that MALDI-TOF could discriminate M.
avium complex (MAC) down to subspecies level. Each strain forms clades corresponding to their
subspecies. For determining host specificity, our results need to be further investigated as we did
not see a host-range relationship. However, it is interesting that there are two MAP clusters that
separate from each other as well as MAH. Other approaches using bioinformatics analysis to
look at specific peaks within spectra (Clinpro tools) and Fourier-Transformed infrared
spectrometry (FT-IR) may be administered for further research of this topic to evaluate host
specificity amongst MAP strains. Overall, as we enhance the breadth and quality of MALDITOF MS database, we demonstrated that a rapid diagnostic test for identification of M. avium is
possible, and thus provide new tools to enable enhanced detection and mitigation of MAP on
farms.
2.6 List of Tables and Figures
Table 1
Comparison of multiplex PCR-ID to MALDI-TOF database (BDAL) and custom
database MSP top match score, for differentiation of MAP and non-MAP.
Isolate ID

State

Isolate
Sources
Waterbuck

Top Match
Score
BDAL♦
1.32

Top Match
Score
MSP∆
1.98

JTC 1536

Florida

JTC 1537

Florida

Impala

1.27

1.27

JTC 1538

California

1.31

2.57

JTC 1539

California

Formosan
Muntjac
Blesbok

1.31

2.59

JTC 1540

California

1.85

2.44

JTC 1542

California

Ellipsen
Waterbuck
Addra
Gazelle

1.10

2.31

PCR ID

Group

M.
Intracellulare
NonMycobacteria
M. avium
hominissuis
M. avium
hominissuis
M. avium
hominissuis
M.
Intracellulare

Non MAP
Non MAP
Non MAP
Non MAP
Non MAP
Non MAP
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JTC 1543

California

Mule Deer

1.79

2.21

JTC 1544

California

1.22

2.38

JTC 1546

Minnesota

1.16

1.9

JTC 1547

Minnesota

Burmese
Thamin
Pygymy
Goat
Elk

1.25

2.17

JTC 1548

Wisconsin

1.63

2.09

JTC 1549

Montana

Pygymy
Goat
Bison

1.18

2.36

JTC 1550

Montana

Bison

1.64

2.44

JTC 1551

California

Waterbuck

1.35

2.23

JTC 1552

Montana

Bison

1.94

2.4

ATCC
49884
ATCC
25291
DT 267

ATCC

-

1.26

1.99

ATCC

-

1.58

1.93

Minnesota

1.44

2.55

DT 268

Minnesota

1.66

2.53

DT 269

Minnesota

1.65

2.70

DT 3

California

1.37

2.41

DT 590

New York

Pygymy
Goat
Pygymy
Goat
Pygymy
Goat
British Red
Deer
Gibbon

1.24

2.52

DT 639

Montana

Bison

1.56

2.62

DT 738

California

Tule Elk

1.8

2.73

DT 774

California

Tule Elk

1.24

2.65

JTC 1094

Wisconsin

Nubian Goat 1.32

2.57

DT 812

Montana

Elk

1.42

2.60

JTC 1180

Florida

Key Deer

1.57

2.45

JTC 1533

-

1.23

2.56

JTC 1250

Barletta’s
lab
California

Hog Deer

1.43

2.7

JTC 1344

Florida

Key Deer

1.77

2.6

M. avium
hominissuis
M.
Intracellulare
M.
Intracellulare
M. avium
hominissuis
M. avium
hominissuis
M.
Intracellulare
M. avium
hominissuis
M. avium
hominissuis
M. avium
hominissuis
M. avium
silvaticum
M.avium avium
M.avium
paratuberculosis
M.avium
paratuberculosis
M.avium
paratuberculosis
M.avium
paratuberculosis
M.avium
paratuberculosis
M.avium
paratuberculosis
M.avium
paratuberculosis
M.avium
paratuberculosis
M.avium
paratuberculosis
M.avium
paratuberculosis
M.avium
paratuberculosis
M.avium
paratuberculosis
M.avium
paratuberculosis
M.avium
paratuberculosis

Non MAP
Non MAP
Non MAP
Non MAP
Non MAP
Non MAP
Non MAP
Non MAP
Non MAP
Non MAP
NonMAP
MAP
MAP
MAP
MAP
MAP
MAP
MAP
MAP
MAP
MAP
MAP
MAP
MAP
MAP
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JTC 1353

Florida

Key Deer

1.2

2.56

JTC 1386

Florida

Key Deer

1.38

2.73

JTC 1528

California

Tule Elk

1.21

2.39

JTC 1529

California

Tule Elk

1.44

2.61

JTC 1527

California

Tule Elk

1.6

2.67

JTC 1531

California

Tule Elk

1.32

0.73

JTC 1532

Minnesota

1.48

2.65

JTC 1534

1.52

2.57

DT 775

Barletta’s
lab
California

Pot-Bellied
Pig
Tule Elk

1.21

2.29

JTC 932

Michigan

Bison

1.34

2.52

JTC 1005

Wisconsin

Bovine

1.67

2.07

W244

Wisconsin

Bovine

1.58

1.66

DT 864

Wisconsin

Bison

1.98

2.57

M.avium
paratuberculosis
M.avium
paratuberculosis
M.avium
paratuberculosis
M.avium
paratuberculosis
M.avium
paratuberculosis
M.avium
paratuberculosis
M.avium
paratuberculosis
M.avium
paratuberculosis
M.avium
paratuberculosis
M.avium
paratuberculosis
M.avium
paratuberculosis
M.avium
paratuberculosis
M.avium
paratuberculosis

MAP
MAP
MAP
MAP
MAP
MAP
MAP
MAP
MAP
MAP
MAP
MAP
MAP

♦ BDAL = Bruker Daltonics (Manufacturer database). Indicates top match scores from manufacturer database.
∆ MSP= customized consensus main spectrum. Indicates top match scores from the customized database.

Table 2: Kappa analysis between PCR and
MSP database has value of 0.739, indicating a
good agreement.

Table 3: Kappa Analysis table,
indicating strength of agreement as
poor, fair, moderate, or good.
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Figure 2: Mass spectrum output (Upper Panel)
shows MAP JTC 1386 fingerprints compared to
isolates ATCC 19698 from BDAL database. Green
peaks represent strong matches, yellow are
intermediate matches, and red are mismatches. The
bottom table displays the top match log score
between both isolates is 1.45.

Figure 3: comparison between MAP JTC 1386
and consensus main spectrum (MSP) of all
M.avium complex isolates. The new MSP
database has top matches log score of 2.73,
which is significantly improved than the BDAL
database on the left.
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Figure 4: Dendrogram generated from a consensus main spectrum (MSP) of M. avium isolates shows clustering at
species and subspecies level. Note that there are two clusters of MAP, two clusters of MAH, and two reference
strains and one non tuberculous strain that does not cluster. The dendrogram displays distance based average relation
algorithm normalized to an arbitrary distance of 1000

Table 4: New MSP library database significantly improves identification accuracy for
64% as compared to BDAL database.
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3. Fourier-Transform Infrared Spectroscopy Project
3.1 Introduction

Previously, MALDI-TOF MS based methods were developed that enabled differentiation
within subspecies of MAP. However, it still was unable to trace the host species of origin, which
is critical for prevention of MAP transmission in herds. The pathogenicity and virulence of MAP
towards specific hosts has not been determined, yet some MAP strains often have host
preference. MAP strain type C dominates infection in cattle, type S in sheep, and type B in bison.
This classiﬁcation only partially reﬂects their host-speciﬁcity, being the types named after the
host from which they were originally isolated. Some cases have demonstrated that the strains can
have overlap in host range, and they may have altered or no clinical signs in other hosts. Thus,
early diagnostic tests to distinguish those types of MAP are required to find the host origin,
reduce livestock morbidity, and to assess potential clinical significance. An advanced diagnostic
tool, Fourier Transformed Infrared Spectroscopy (FT-IR), is one potential approach for precise
characterization of MAP types. The instrument is able to generate a distinct infrared fingerprint
spectrum that could potentially discriminate various types of MAP by absorbing infrared
radiation of specific MAP mycolic-acid rich regions. Furthermore, a previous study has proven
that FT-IR is able to differentiate various strains of M. fortuitum, and it facilitates classification
of microbial multispecies populations (Rebuffo Scheer et al.,2017). However, there is no
information on the evaluation of this technology looking at the strain level of MAP, including its
host type. Hence, our goal was to look for specific cell surface biomarkers that characterize the
host types of MAP based on the IR spectral fingerprints and to arrange a hierarchical cluster
agreement (HCA) portraying the clustering of isolated strains. Genome information indicates C,
S and B type strains of MAP are distinct. This means that the molecular composition of each

A n t o n i k a | 33

type of MAP likely differs, particularly the mycolic-acid region (Bryant et al.,2016). We
hypothesized that FT-IR will allow differentiation of MAP strains based on the host range (C, S,
and B type)
3.2 Materials and Methods
Bacterial strains: A total of 57 bacterial isolates that include 33 MAP isolates, 22 nonMAP isolates, and 2 ATCC references strains were used in this project. The field isolates were
previously identified with morphologic and genomic approaches by PCR at Dr.Collins’ lab at UWMadison and ATCC. The species of the isolates comprised of M. avium complex members: M.
avium ssp paratuberculosis, M. avium ssp hominisuis, M. intracellulare, M. avium ssp avium, M.
avium ssp silvaticum, and non-tuberculous mycobacteria. The strains were isolated from different
states with broad host ranges such as bison, cattle, elk, pig, deer, goat, gibbon, waterbuck, blesbok,
and thamins.
FT-IR Sample Preparation: The method for this research project was developed
independently in Dr. Loy’s lab using multiple dilution factors. The bacterial isolates were grown
at 37°C in the liquid media Middlebrook 7H9 supplemented with OADC and ferric-mycobactin
J. Upon 2-3 weeks growth (depending on the strain), the cultures were centrifuged for 15
minutes at 2500 rpm and the supernatant discarded. The pellet was suspended in 70% (v/v)
ethanol and water, then the sample was transferred to the suspension vials containing metal bars.
For each dilution factor, the cells were homogenized by vortexing and pipetting up and down.
Six replicates with different dilution factors were made for each individual strain. Next, the
homogenized samples were spotted on the FT-IR target plate and incubated at 37°̊C for 5
minutes. The spectral analysis was carried out using an IR Biotyper System (Bruker Daltonik,
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Bremen, Germany) and Opus Software with the default analysis settings as recommended by the
manufacturer.
3.3 Results
MAC Infrared Spectra
Figure 5 displays infrared spectra profiles of five different strains of M. avium complex
(MAC) and one non-mycobacteria (Moraxella bovoculli). All strains had intense bands in the
3300 cm-1 region. Two strong bands located in the 2800 and 3000 cm-1 regions presented in five
strains of MAC spectra, while the non-related strain Moraxella did not. No major differences
were observed between five strains of MAC. However, M. avium avium and M. avium
hominisuis seemed to have a unique peak present in the 1750 cm-1 region and one small peak at
3000 cm-1.
Host Species of MAC
There was no relevant group of host species of origin present in the non-MAP
hierarchical cluster analysis (HCA) as in Figure 6. Nevertheless, analysis based on the isolates
location (Table 1) showed strains (JTC 1551, JTC1538, JTC 1541) and (JTC 1540 and JTC
1543) from California formed groups. The optimal cut off for this dendrogram was the lowest
(Figure 6) having value of 0.002, and most isolates have cluster purity colored orange indicating
“medium”. The cut-off value refers to their genetic distance. Small cut off values indicates close
relation between strains. Figure 7 portrays HCA of MAP host species of origin. Some isolates
from similar hosts do cluster together. One cluster comprising JTC 1344, JTC 1180, and JTC
1341 belong to the same host of key deer. Similarly, DT 774 and 775 from Tule Elk clustered
together. The optimal cut-off is 0.09 varying cluster purity from medium (orange), bad (yellow),
and good (green). There was no clustering based on location observed in MAP dendrogram.
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Differentiation of MAP and Non-MAP
The collection of MAP and non-MAP IR spectra were compiled together generating the
dendrogram in Figure 8. The optimal cut off for this dendrogram was the highest (0.12) and the
cluster of all MAP isolates were “good”, but the non-MAP isolates were “medium”. Two big
clusters of MAP were observed, one on the top and the bottom. One cluster of non-MAP was
present, but there was an outlier of M. silvaticum. Figure 6 depicts characterization of non-MAP.
There was no significant grouping found.
3.4 Discussion
Characteristics of MAC IR Spectra
The spectra of FT-IR possess unique and distinct characteristics from MALDI-TOF spectra.
Infrared spectra are measured based on the energy absorbed due to breaking bonds of functional
groups in the cell surface components (Davis & Mauer, 2010). Different bacterial species have
complex cell surface components, enabling production of distinct IR fingerprints for each
species. As any other mycobacteria, specific components of MAC will be in their mycolic acidrich cell wall (Chatterjee, 1997). The composition of mycolic acid is abundant with fatty acid
(Volha Shapaval et al.,2019). The stretching of fatty acid bonds will appear in the region 2800
cm-1 to 3000 cm-1 (Volha Shapaval et al., 2019)as is shown in Figure 5 of the five strains of
MAC. The 3300 cm-1 region signifies amide bonds stretching in the nucleic acid, hence all the
bacterial isolates must have intense peak in this region. As MAC is Gram-positive, there should
be no band observed in the 1200 cm-1 region, as this indicates the presence of polysaccharides.
On the other hand, Moraxella bovoculi, which is a Gram-negative, is lacking the peak in this
region. M. bovoculli has been known to have high genetic diversity and distinct virulence factors,
especially in the capsular polysaccharide (Dickey et al., 2018). This could indicate that the M.
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bovoculli IR spectra in Figure 5 may not have a high amount of polysaccharide. The strong band
in the 1750 cm-1 region demonstrates the presence of amide bonds in the peptide. This signature
is specific to M. avium avium and M. avium hominisuis. It is unclear what type of protein is
indicated by this band, but a study revealed that M. avium hominisuis emerged from M.avium
avium after adaptation to mammals(Mijs et al., 2002). Supporting this concept of relatedness,
both strains had a small peak at 3000 cm-1.
Host Species of Origin of MAC
Although a study (Alonso-Hearn et al., 2017)of fatty acid profiling reveals changes in
MAP cell structure after infection in the host macrophage, the results summarized in Figure 7
and 8 do not reflect the IR capability to find the differences. The pattern of the mycolic acid
region in 2800 to 3000 cm-1(Figure 5) between strains of MAC may look slightly different, but
this change is insignificant and there is no standard pattern that signifies the changes of the
different host species of origin. The fact that Figure 7 has two host species of origin clusters
implies that MAP may undergo more host-adaptation changes than non-MAP species. For
bacteria to evolve, cell division time and the host environment are the biggest factors. Hence, in
Figure 7, some MAP isolates that are not clustering may not have sufficient factors to undergo
adaptation in their new hosts.
Differentiation of MAP and Non-MAP
FT-IR could be a better instrument than MALDI-TOF for bacterial differentiation
because the IR spectra generated provide specific signature bands from each bacterial species
that are present on the cell membrane. MALDI-TOF spectra works by matching the peptide
fingerprints generated from intracellular proteins and enable comparison between the database
and isolates (Croxatto et al., 2012b), but the peaks in the fingerprints are not signify the chemical
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molecules present in the bacterial cell. Thus, analysis for distinct bacterial species will be easier
with the IR spectra on the basis of the cell membrane composition. The Figure 5 dendrogram
shows very clear differentiation of MAP and non-MAP, and Figure 5 is also similar to MSP
dendrogram in Figure 4 (2.6). Two clusters of MAP emerge with one closely related to the nonMAP and the other has farther distance. The optimal cut off point is the highest for Figure 8,
representing best clustering. Non-MAP subspecies can also cluster together as shown in Figure
9, but there is no relevant explanation pertaining the relative closeness between subspecies since
there were no major similar IR spectra found. As in Figure 5, M. avium silvaticum possessed
band patterns similar to that M. intracellulare and MAP. This may explain their subspecies
correlation, although this fact is still inconclusive because the band patterns are distinct for each
replicate from the same isolates. The major disadvantages of FT-IR are similar to MALDI-TOF,
which is in the sample requirements and preparation. Depending on the characteristics of each
MAC colony, the treatment, dilution factor, and band pattern emitted will be diverse for each
sample. This makes analysis of the IR spectra more challenging. Work has been done in this
project using a spectrophotometer to allocate the same optimum optical density for each sample.
Nevertheless, there was no good standard of OD observed for each isolate, and it was also
dependent on the colony morphology. Some colonies are wetter have more cells; hence, when
such a colony is taken in one full inoculation loop, it creates too much noise. On the other hand,
the waxy and dry colonies have fewer cells; thus, more than one full inoculation loop is needed
and extra time for vortexing to get high quality IR spectra.
3.5 Conclusion
In general, both MALDI-TOF and FT-IR are promising instruments for quick and fast
detection and identification of MAC. Precise characterization of non-MAP and MAP is also
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possible using these two instruments. However, FT-IR more useful than MALDI-TOF for
spectra analysis. Researchers could easily detect the signature band pattern on the basis of
bacterial cell wall composition, providing enhanced certainty of sample identification. Besides
that, the HCA dendrogram could be customized to diverse categories within one spectral
collection. As for tracking the host species of origin of MAC, the result is still indecisive because
the HCA results are not consistent. However, there may be application for this technology
regarding host-origin for other bacterial species that undergo quick host-adaptation and have
external cell structure such as capsule. Host species of origin in MAP could be partially
identified as in Figure 7. Possibly, these isolates have adapted to their host and change their
bacterial components, whereas other MAP isolates that are not clustering are still undergoing
slow adaptation in the host with less change. Since non-MAP are mostly present in wildlife,
there is less evidence showing their adaptation to specific hosts. They could become
opportunistic pathogens to any hosts. For instance, M. avium avium, which is naturally found in
the avian group could cross infect porcine for an indefinite time of evolution until it was tested to
have a distinct genome and subdivided to be M. avium hominissuis (Mijs et al., 2002). Hence,
Figure 6 is consistent with this study. The overall optimal cut-off for MAC is relatively low
because of their complex bacterial structure and colony morphology, in addition to inequivalent
sample preparation treatment (e.g different dilution factor and timing of vortexing). Obtaining
good spectra remains the most challenging aspects for both MALDI-TOF and FT-IR instrument.
The slow growth of MAC impedes the ability for rapid identification of MAC in the clinical lab,
but the technology procedures are faster and cheaper as compared to other serological or
multiplex PCR testing (Shin et al., 2010).
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3.6 List of Tables and Figures

Figure 5: IR spectra profiles of five strains of MAC and one non-related strain of
Moraxella.

Figure 6: Dendrogram based on the host species of origin of non-MAP. Second column indicates
cluster purity signified as green as “good”, Orange as “medium”, and yellow as “bad”. On the top
left, the optimal cut off is 0.002, the lowest among three other HCA analysis of this research.
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Figure 7: Displaying Hierarchical cluster analysis (HCA) of MAP in relation to the host
species of origins. The cluster purity is varied and the optimal cut off is 0.09.

Figure 8: Showing characterization between MAP and non-MAP. The cluster purity of MAP are all
green demonstrating “good” purity, except four strains in the middle cluster having orange color
(medium). All strains of non-map has orange color representing “medium” purity.
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Figure 9: Depicting differentiation of the members of MAC.
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B. Chapter 2
4 Background and Literature Review
4.1 General Introduction of Porcine Reproducive and Respiratory Syndrome
(PRRS)
Porcine Reproductive and Respiratory Syndrome (PRRS) is one of the most devastating
diseases in swine after the eradication of classical swine fever. The history of PRRS began in the
late 1980s, where it first emerged in North America. Another lineage appeared in Europe in
1990, continuing to spread globally (Lunney et al., 2010). The etiologic agent of PRRS is PRRS
virus—a single-stranded, positive-sense RNA virus belonging to the family Arteriviridae.
Clinical signs of PRRS include reproductive failure, infertility, birth defects in piglets, severe
respiratory disease manifesting in pneumonia, and impaired growth, ultimately sometimes
ending in death. PRRSV invades the immune system specifically macrophage in the lung. In
some cases, it can promote more severe secondary infections, such as bacterial pneumonia. It has
been identified that PRRSV diverged into two types: European lineage (Type 1) and North
American lineage (Type 2) (Kappes & Faaberg, 2015). Type 2 appears to have more
heterogeneity as compared to Type 1, making it more virulent. Both lineages have only 65 %
genetic similarity (Kimpston-Burkgren et al., 2017). Thus, it creates variation between strains.
PRRSV variability causes difficulty in control and prevention strategies. Vaccination is one of
the most widely used control strategies for PRRSV, but it does not give 100% protection for the
herds. Current vaccines, such as modified live vaccine (MLV), could be a successful approach,
yet they only works against the strains similar to the corresponding vaccine (Kimpston-Burkgren
et al., 2017). As a result, PRRSV is very economically significant since it causes a high level of
morbidity, leading to a billion-dollar loss in the swine industry. At present, the transmission of
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PRRSV has extended throughout the world, excluding Australia, New Zealand, Brazil, and
Switzerland (OIE). In the United States only, the annual losses due to PRRSV infection has been
estimated to be $664 million in 2005 to 2010. Further research still needs to be done to
understand the more profound characteristic of pathogens in order to develop better solutions in
minimizing the spread of the pathogen (World Organization for Animal Health, 2008).
4.1.1 Viral Genome and Structure
The full-length genome of PRRSV has been known to have a total size of 15 kb (Kappes
& Faaberg, 2015). The PRRSV genome is a positive sense, single-stranded RNA, which is
flanked by a 5’ methyl cap and 3’ polyadenylated tail (Sun., 2017). There are 11 open reading
frames (ORFs) present in the genome. ORF 1a and 1b encode for non-structural proteins, and
ORF 2-7 encode for structural proteins. Synthesis of ORF 1a and 1b produces large polyproteins,
namely pp1a and pp1ab. The polyprotein pp1a is post-translationally modified into ten functional
non-structural proteins (nsps) via cleaving during complex proteolytic cascades. Four putative
proteinase domains encoded in ORF 1a instruct this process. The ten functional proteins are
nsp1α, nsp1β, nsp2, nsp3, nsp4, nsp5, nsp6, nsp7α, nsp7β, and nsp8. The polyprotein pp1ab
undergoes similar proteolytic cascades generating four nsps: nsp9, nsp10, nsp11, and nsp12. A
new ORF was recently discovered, namely -1/-2 ribosomal shift signal and Trans Frame (TF),
located in the central region of ORF 1a. TF synthesizes two viral proteins: nsp2TF and nsp2N
(Li et al., 2014).
The rest of the ORFs are responsible for the PRRSV structure assembly. ORF 2a-4
encode for minor N- glycosylated envelope proteins: GP 2, 3, and 4. The glycoproteins form a
heterotrimer linked by disulfide bonds. ORF 5-7 encode for one glycosylated and two nonglycosylated major structural proteins: GP 5, N, and M proteins. GP 5 and M protein interact and
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form heterodimers. The minor GPs have been found to bind to cellular receptor CD 163
necessary for viral infectivity (Das et al., 2009). ORF 2b, integrated within ORF 2a, generates E
non-glycosylated envelope protein required for viral uncoating and viral release in the
cytoplasm. The N (nucleocapsid) protein is a dimer essential for viral particle formation through
interaction with the viral genome (Dokland, 2010).
The viral structure of PRRSV is known to be spherical or oval with a diameter of 50-60
nm. Through the cryo-electron microscopy (EM) image, the enveloped surface lacks spike, and
the viral glycoproteins embedded in the lipid bilayer surface are exposed. Inside the virus, the
genome is enclosed by a capsid. Previous studies indicated PRRSV had icosahedral symmetry,
yet Dokland et al. (Dokland, 2010) found that the virus has a loosely filamentous structure of
helical coils. Inside the virion, there is a nucleocapsid (N) protein that is forming a two-layered
structure with protein dimers linked into a twisted chain with the RNA in the middle (Doan &
Dokland, 2003). The RNA genome connects with the N-terminal domain of the nucleocapsid,
while the C-domain becomes the foundation of the capsid structure. The N protein is
phosphorylated, and it is proposed that it might function for protein interaction and RNA
binding(Doan & Dokland, 2003).
4.1.2 Viral Infectivity and Replication
PRRSV has restricted tropism in host cells as it is only able to replicate in a few cell types
(Gao et al., 2013). PRRSV is only infectious to porcine alveolar macrophages (PAMs) and
developing monocytes. Since primary PRRSV research is usually done using monkey kidney
derived cells such as MARC 145 and MA 104, its biological relevance concerning its tropism is
still questionable. None of the cell lines used for PRRSV research are derived from porcine,
which is one of the PRRSV research discrepancies (Mulupuri et al., 2008).
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Several potential PRRSV viral receptors have been discovered, namely sialoadhesin (CD
169), vimentin, heparan sulfate, CD 151, and CD 163 (Kimpston-Burkgren et al., 2017).
However, further research might need to be done for four of these receptors, except sialoadhesin
and CD 163, which have been extensively studied in the past. The mechanism of viral entry
starts with the binding of GP 5/M structural protein to sialoadhesin and heparan sulfate. Then,
the interaction of GP 2a protein with CD 163 provides viral attachment and invagination of host
cells (Tian et al., 2009). Upon entering the host cell, PRRSV E protein act as an ion channel that
senses changing pH. Once pH is under the right condition, it releases signal to uncoat viral
particles, exposing the genome (standard clathrin-mediated). In spite of that, it was discovered
that CD 169 binding is not necessary for viral entry, but instead, CD 163 is the critical factor of
the viral entry (Verheije et al., 2003). Overexpression of CD 163 in several non-permissive cells
allows them to become susceptible to infection, which demonstrates that CD 163 is the center of
viral entry and attachment.
Viral replication begins in the cytosol after clathrin-mediated endocytosis. Viral
membrane fuses into the endosomal layer, then the genome is released. ORF 1a and 1b are
translated to form long polyprotein, which subsequently processed to be NSPs (non-structural
proteins). NSPs form what are called replication and transcription complexes (RTCs), which
accumulate at the virus-induced-ER-derived double-membrane vesicles (Yu et al., 2015). The
RTCs then initiate synthesis to produce both full-length and sub-genomic length minus-strand
RNA (-sg RNA). The full-length minus-strand RNA will be the template for genome replication.
The -sgRNA will function as the template for the synthesis of several sets of sg mRNAs, which
are required to generate viral structural proteins. Host ribosomes translate these mRNA for
structural proteins. While approaching the late stage of viral replication, N proteins will attach to
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newly synthesized viral RNA forming the nucleocapsid complex. After encapsidation, the virion
will bud into the Golgi complex and/or lumen of smooth ER. As viral particles accumulate inside
the cell, it will be released into extracellular space via exocytosis.

Viral entry and replication of PRRSV. Image courtesy of Lunney et al.

4.1.3 Viral Infection and Host Immune Modulation
The early post infection of PRRSV after initial exposure (PI) is described commonly by
the presence of several clinical signs and abundant viral loads in the target cells: alveolar and
tissue macrophages. This acute phase usually last for up to one month, followed by a late
persistent phase. During the late phase, PRRSV replicates to low viral load and it resides
primarily in the lymphoid tissues. Ultimately, the virus will be cleared from the body after
approximately 150 days after PI or more. The actual mechanism of PRRSV persistence is
unknown, but a major influencing factor which causes persistence could be the inability of the
host immune response to provide protective immune response (Lopez & Osorio, 2004).
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Like other types of viruses, the host immune response will start from innate immune
factors such as physical barriers, skin barrier, protease, lipid, and pH. Non-specific white blood
cells including natural killer (NK) cells, eosinophils, and macrophages also protect the host and
induce an adaptive immune response. The most critical white blood cell at this stage is the NK
cell, as it involved in cytotoxicity activity and recruiting T- and B-cells. Sentinel immune cells,
such as macrophages and dendritic cells, activate NK cells through the secretion of type 1
Interferon (IFN), Interleukin -12 (IL-12), and cytokines. Activated NK cells will secrete perforin
and granzyme to kill target cells that are lacking major histocompatibility class I (MHC-1), and
also produce cytokines, like IFN-γ, to recruit adaptive immune cells. PRRSV suppresses
production of type 1 IFN in infected pigs. Five PRRSV nonstructural proteins (nsp1α, nsp1β, nsp2,
nsp4, and nsp11) and one structural protein (N) are responsible for this inhibition (Nan et al., 2017).

The next line of defense that the host cell would use after an innate immune response is
the adaptive immune response. Antigen-presenting cells, such as dendritic cells, will present
antigens with MHC class 1 to recruit T-cells and activate B-cells to produce antibodies. Past
studies have investigated neutralizing antibodies against homologous PRRSV. Nine-Eleven-days
post-infection, it was observed that non-specific immunoglobulin M (IgM) was produced (Gao et
al., 2013). Specific antibody, such as IgG response, was detected ten days post-infection. These
antibody responses can be more potent for homologous PRRSV. However, for heterologous
PRRSV, this immunity is insufficient and won’t give reliable protection against both type 1 and
type 2 strains.
Immunology research continues to investigate memory B-cells and plasma cells
regarding PRRSV infection. Memory B-cells were extracted from tonsil, lymph nodes, and
spleen. It was shown that memory B-cells have a robust immune response against nsp2, GP5,
and nsp7 viral proteins (Sun., 2017). However, there are still many questions that have not been
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answered regarding the immune response of PRRSV. Also, it is not known how the immune
response works specifically for the two different types of PRRSV.
It was demonstrated that a significant immune response was caused by structural
glycoproteins. Still, recent research using chimeric virus does not give evidence that a potent
immune response is only due to glycoprotein (Tian et al., 2009). The researchers suggest that
other proteins yet to be discovered may be responsible for inducing a robust immune response.
4.2 Vaccine and Antiviral Strategies
4.2.1 Live Attenuated Viral Vaccines
Knowing the importance of vaccines to reduce the transmission of PRRSV, many studies
on vaccines have been conducted. One of the most popular vaccines researched is a live
attenuated vaccine. This type of vaccine strategy is known to be the most effective for many
different kinds of viruses. One of the main techniques to develop a live-attenuated viral vaccine
is to serially passage the virus in another type of cell line to reduce viral infectivity. Upon a
certain level of attenuation, the virus can be inoculated into a pig (Verheije et al., 2003). This
vaccine is very efficient because it generates a potent immune response even without knowing
the specific mechanism of the viral immune modulation or host immunity. However, the
disadvantage is that this vaccine can protect only homologous PRRSV. It fails to prevail against
heterologous PRRSV. Another attempt to improve vaccine efficacy was done by Verheije and
his team. They slightly modified the parental strains of PRRSV by inserting two amino acid
residues in the GP2 (Verheije et al., 2003). In addition, they also changed the M protein with
murine lactate dehydrogenase found in arterivirus and deleted 6 amino acids of the c terminus of
N proteins. These three modified live attenuated viruses were subjected to a challenge study.
Nevertheless, these vaccines were found to be ineffective because they could not protect the pigs
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against infection after immunization, although they could suppress viremia. Only the second live
attenuated vaccine was found to be effective.
Nowadays, the most widely used vaccine is PRRS MLV by Ingelvac. It has been used for
several years to suppress the transmission of the virus on farms. Yet, this vaccine does not give
broad protection, and it is only valid for the viral strains related to the vaccine. Herd prevalence
level is still high, and control is limited (Vu et al., 2015). Surprisingly, the PRRSV live
attenuated vaccines fail to give full protection for different types of PRRSV, whereas vaccines
from other members of the same arterivirus family, such as equine arteritis virus (EAV), are
highly efficient against variation of EAV(Nan et al., 2017).
4.2.2 Synthetic Virus Vaccine Candidate
Another approach that has been taken to extend broader protection against PRRSV is by
using chimeric viruses possessing a centralized gene. In a previous study (Vu et al., 2015), a
centralized gene was constructed by creating a consensus viral genome from 59 non-redundant,
whole-genome sequences of PRRSV type 2. This study was able to create a synthetic virus
designated as PRRSV-CON successfully. Results suggest that PRRSV-CON has improved
heterologous protection among variants of PRRSV, particularly type 2 PRRSV. Thus, it has
potential to be one of the most efficient vaccine candidates. The mechanism of how PRRSVCON can generate a potent immune response is poorly understood, but it is assumed that the
glycoprotein is the main reason. The glycoprotein was described to be a potential molecule
inducing an immune response, other proteins may also be involved, such as GP5, M, and N
protein. Upon finding the immunity mechanism of PRRSV-CON, similar strategies of
vaccination could be employed, except, instead of using a consensus genome, these should focus
more on the viral genes that can induce protective immunity.
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4.2.3 Antiviral for PRRSV
The current trend of PRRSV research lies in the development of an antiviral. Some
effective antivirals have been discovered. Two molecules that are known to inhibit viral
replication are miRNA and nanobodies. Zhang and associates found that the miRNA -23 host
factor can upregulate type 1 IFN by activating interferon regulatory factor 3 (IRF 3) and IRF 7.
The result indicated that miRNA -23 is a potent suppressor of PRRSV infection by directly
binding to the PRRSV genome and subgenome in its replication cycle, hence this miRNA could
be potential antiviral (Qiong Zhang et al., 2014). Furthermore, miRNA -181 also exhibited
inhibition during viral replication by binding to the ORF 4 (Dhorne-Pollet et al., 2019). Despite
having antiviral properties, there some particular miRNA that are proviral. For instance, miRNA
-373 targets nuclear factor one and other associated kinases. As a result, it will impair IFN β
production, which then promotes viral replication into the host. Lastly, recent research found that
nanobodies, a single-chain antibody fragment derived from Camelidae heavy chain (VHH), can
target specific viral proteins. In the case of PRRSV, the nanobodies bind to nsp9 and nsp4, which
are essential for the viral genome. Wang and associates attempted to express this nanobody into
MARC 145 cell lines, which, in turn, exhibited antiviral properties against viral proteins,
including pp1a and pp1b (Wang et al., 2019). Thus, this antiviral could be a potential treatment
for PRRSV infection.
4.3 PRRSV Project Objective
PRRS is one of the major viral diseases responsible for huge economic losses and
morbidity in the swine industry. Clinical signs of PRRS include chronic respiratory disease
among young pigs as well as a reproductive failure of pregnant sows. The etiologic agent of
PRRS is the PRRS virus— a positive single-stranded RNA-enveloped virus. There are two types
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of PRRSV circulating worldwide classified as PRRSV-1 (European) and PRRSV-2 (North
American). PRRSV has a genome size of approximately 15 kb, with ten open reading frames
(ORFs). Genetic variations among PRRSV is common as the virus is prone to mutation.
Nevertheless, PRRSV-2 displays greater antigenic heterogeneity than PRRSV-1 exhibiting
distinct properties of their surface glycoprotein. Their sequence similarity is 60% (Vu et al.,
2015). Multiple variants of PRRSV can easily spread among a herd, imposing considerable
challenges for finding optimal vaccine protection. Although various vaccines for PRRSV are
already available in the market, none of those vaccines can administer broad protections for both
strains. The most effective vaccine—a modified live virus vaccine (MLV) —is made from type 1
PRRSV and will only protect against type 1 PRRSV. It is ineffective against type 2 strains
(Kimpston-Burkgren et al., 2017).
To overcome this genetic variation, a well-known vaccine strategy has been developed by
generating a synthetic virus vaccine that contains centralized sequences. In a previous study (Vu
et al., 2015), consensus viral-genome was constructed from 59 non-redundant, whole-genome
sequences of type 2 PRRSV to produce synthetic virus (PRRSV-CON). The study confirmed that
PRRSV-CON had broadened the level of protection for type 2 PRRSV strains. However, despite
this success, the mechanism of how PRRSV provides immune protection has not been
determined. Specifically, it is not clear which viral proteins are capable of eliciting optimum
immune responses.
The objective of this project was to study the relative contribution of PRRSV structural
proteins in inducing swine immunity through a reverse genetic system. Structural proteins of
PRRSV are most likely the contributor of viral infectivity because these proteins are the binding
sites of an antibody. Thus, we hypothesize that structural proteins of PRRSV can elicit maximum
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immunity. The location of these structural proteins is found in the open reading frame ORF 2 to
7. ORF 2-5 contains surface glycoproteins, and ORF 6-7 bears proteins required for viral particle
and capsid formation (Dokland, 2010; Music & Gagnon, 2010).
4.4 Material and Methods
Cells, Antibodies, and PRRSV Strains
MARC-145 cell lines derived from monkey kidney cells were utilized in this experiment.
The cells were cultured in Dulbecco’s modified Eagle’s medium (DMEM) and supplemented
with 10% fetal bovine serum (FBS) in the 37 °C incubator with 5% CO2. Type 1, type 2 PRRSV
cDNA clones (pSD01-08 and pFL12), DH5α bacterial competent cells, and the monoclonal
antibody SDOW 17 for in vitro tests were obtained from the stocks of previous research
(Kimpston-Burkgren et al., 2017). The secondary antibody—Alexafluor-488 conjugated donkey
anti-mouse antibody was purchased from Invitrogen. Plasmid (pUC57-AMP) containing PasI,
SbfI, PacI, 3’UTR, HDVRz (hepatitis delta ribozyme), and XbaI sequences were synthesized
artificially through a contract with a biotech company for insertion of new restriction sites (Table
1).
Method 1: Generation of type 1 modified PRRSV
Due to the absence of the closest restriction sites in ORF 2, a single restriction site (SbfI)
was added, as seen in step 1, Figure 6. To insert the new restriction site, the pSD01-08 plasmid
was digested with PasI and XbaI restriction enzymes, generating three fragments: fragment one
from XbaI to PasI#1 site (13,794 bp), fragment two from PasI#1 to PasI#2 site (3,978 bp), and
fragment three from PasI#2 to XbaI site (903 bp). Fragment 1 and pUC57-AMP were digested
with PasI and XbaI, and the corresponding fragments were ligated. The resulting plasmid had a
large deletion from PasI to end of ORF7, designated as an intermediate 1 plasmid. The plasmid
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was transformed into DH5α competent cells according to the protocols from New England
Biolabs. Positive clones were assessed by digestion and sequencing. Next, the non-structural
PRRSV-1 genome was amplified through PCR, including flanking of SbfI site to the reverse
primer. The resulting PCR fragment was cloned into the intermediate 1 plasmid to produce
intermediate 2 plasmid, which contained SbfI new sites and non-structural protein of PRRSV-1.
Furthermore, to complete the genome of PRRSV-1, a second PCR containing the entire
structural genes (ORF2-7) of PRRSV-1 was amplified and cloned into the intermediate 2
plasmids, under SbfI and PacI restriction enzyme sites. Positive clones were assessed by
digestion and sequencing, as the previous steps. The resulting plasmid containing the full-length
sequence of pSD01-08, with the new restriction enzyme inserted at the 5’ end of ORF2 and 3’
end of ORF7, was designated pmSD01-08.
Method 2: Transfection to recover modified type-1 PRRSV
To recover the virus, pmSD01-08 was transfected into MARC-145 cells, using the
TransIT-cDNA transfection kit (Mirus Bio). Prior to transfection, the cells were seeded for 24 h
in 6 well plates and observed for confluency. The plasmid was mixed with Opti-MEM reduced
serum media and TransIT reagent according to the protocols. The transfected cells were cultured
in DMEM containing 10% FBS and incubated at 37 °C with 5% CO2. After 4 hours of
incubation, the media on the transfected cells was changed with fresh complete DMEM media,
ensuring optimum transfection process. The cytopathic effects (CPE) were evaluated for five
days post-transfection, and the supernatant was collected as a stock virus for future studies.
Method 3: Indirect-Immunofluorescence Assay (IFA)
Immunofluorescence assay was performed to evaluate the reactivity of the virus towards
PRRSV specific monoclonal antibody (mAB). The transfected cells from the preceding steps

A n t o n i k a | 54

were washed twice with phosphate buffer saline (PBS) (pH 7.4). The cells were fixed with 4°C
Acetone-Methanol (1:1) and incubated for 15 minutes, followed drying at room temperature.
Next, SDOW17 PRRSV mAB from mouse was added as a primary antibody to the fixed cells
and incubated at room temperature in the shaker for one hour. Finally, the secondary antibody
(Alexafluor-488 fluorescence conjugated antibody) was administered after washing three times
with PBS to remove the primary antibody. The cells were incubated (RT) in the shaker for one
hour in addition to wrapping the plates with aluminum foil to prevent the absorption of light.
Finally, the fluorescence signal was observed under a fluorescence microscope.
Method 4: Genome swapping of modified type 1 PRRSV and type 2 PRRSV
pFL12 structural genes (ORF 2-7) were amplified by PCR using a pair of primers that
contain restriction enzyme SbfI and PacI. The PCR product was cloned into the pmSD01-08
under SbfI and PacI. The resulting synthetic plasmid designated as pSDFL27 had non-structural
proteins from PRRSV-1 and structural proteins from PRRSV-2. The subsequent steps were the
same as method 2 and 3.
4.5 Results
Insertion of Sbf1 restriction sites
There was no closest restriction enzyme found in the pSD01-08 (PRRSV-1), which was
the backbone for our construct. Therefore, a short synthetic DNA fragment containing three
restriction sites was generated to aid the subsequent cloning steps. The synthetic DNA fragment
was synthesized by a biotech company and was delivered in a plasmid labeled pUC57-AMP.
This synthetic DNA was successfully added in pSD01-08, displayed in Figure 1. Figure
2 depicts the full-length construct of pmSD0-08 (PRRSV-1) with additional SbfI and PacI sites.
There were two positive clones (clones# 2 and #3) for pmSD01-08. These two clones were
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digested with several restriction enzymes to confirm their authenticity (Figure 4). Lane 1, the
clones were cut with SbfI and AscI; lane 2 with AscI and EcoRV; lane 3 with SbfI and EcoRV.
The size of the bands was similar to the gel simulation in software SnapGene. Moreover, two
plasmids (intermediate1 and pmSD01-08) were run into the gel electrophoresis to verify the
integration of non-structural proteins and structural protein sequences (ORF 2-7) of PRRSV-1
into intermediate 1 (Figure 3). The intermediate 1 has lower base pairs than pmSD01-08. Hence,
in lane 1 (Figure 3), the band moves further.
Modified type-1 PRRSV (pmSD01-08) Recovery
Validation whether pmSD01-08 is infectious was done by transfecting the plasmid into
MARC-145 cells. After five days of transfection, CPE was spotted in the light microscope,
suggesting pmSD01-08 to be infectious. Therefore, we conducted immunofluorescence assay
(IFA) with an antibody specific for PRRSV from the infected mouse to prove the infectivity of
the cells. To control the transfection efficiency, a plasmid encoding green-fluorescence protein
(GFP) was included. Figure 5A exhibits the fluorescence signal observed from the well
transfected with GFP plasmid. For positive control, an infectious clone designated NCV1 that is
known to produce infectious virus after transfection was used. The strong fluorescence signal
was observed from cells transfected with the NCV1 infectious clone (Fig. 5B). Finally, Fig 5C
and 5D show the fluorescence signal observed from cells transfected with the pmSD01-08
plasmid clone#2 (Fig 5C) and clone#3 (Fig 5D). Both clone# 2 and clone#3 were infectious
since it is bound to the antibody and emitted green fluorescence. Clone#3 (Fig 5D) appears to be
more infectious than clone#2 (Fig 5C) based on the observation in immunofluorescent
microscope.
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Recombinant PRRSV (pSDFL27) is not infectious.
Confirmation of pm SD01-08 from the previous step enabled the production of chimeric
plasmid called pSDFL27. This plasmid contained the genome of non-structural proteins from
PRRSV-1 and structural protein from PRRSV-2. PRRSV-1 functions as a vector to express
PRRSV-2 structural proteins in this case. After transfection in MARC-145 as in method 3, the
result from pSDFL27 transfected cells showed no CPE. IFA also verified this result, as shown
in Figure 7. No green fluorescence light emanated (Fig 7A). Thus, the virus was not produced in
the cell and no antibody binding to the virus. This construct pSDFL27 was not infectious and
could not be recovered in the cells.
4.6 Discussion
The mechanism by which PRRSV induces immune protection remains unclear in
vaccinated or wildly infected swine. Previous research has assessed the four highly variable GP
of PRRSV located in ORF 2-4 (Kimpston-Burkgren et al., 2017). Nevertheless, the antibody
raised against these glycoproteins is not fully neutralizing, implying that other proteins play a
role in the antibody neutralization. Thus, in this research, we hypothesized that the whole
structural proteins of PRRSV (ORF 2-7) are involved in the induction of antibodies. The proteins
produced from ORF 5-7 may have potential epitopes that can bind to the antibody. ORF 5
produces GP 5, and ORF 6 encodes for M proteins, and ORF 7 generates N protein dimers. GP 5
and M protein form heterodimers that have been known to interact with sialoadhesin (van
Breedam et al., 2010). The N-protein cooperates with the viral genome to viral assembly
particles. All of these proteins have been reported to have significant roles in viral infectivity
(Qingzhan Zhang & Yoo, 2015). In this study, we used PRRSV-1 strain (pSD01-08) as the
backbone of the viral vector to deliver the whole structural protein of PRRSV-2 strain. As both
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strains have less genetic similarity, they are not cross-protecting (Choi et al., 2016). Therefore,
the pSD01-08 infectious clone (PRRSV-1) is suitable for the expression of the PRRSV-2
structural genes because it will produce the structural proteins in their biological forms. The
construct for the vector required insertion of restriction sites to enable swapping between both
strains. We successfully modified the vector pmSD01-08 with these new insertion sites (Figure
1), and the vector could be demonstrated in the MARC-145 cell (Figure 5). The construction of
pSDFL-27 was done after swapping structural proteins of the vector with PRRSV-2. However, in
the transfection step, pSDFL 27 was not infectious, as in Figure 7. This occurred possibly due to
the substitution of N-protein (ORF 7) between type 1 and typed 2 PRRSV in pSDFL27
interfering viral assembly.
N-protein is a viral nucleocapsid required for viral particle formation. This protein assists
the structural proteins to interact and assemble with the viral genome, producing a complete
infectious viral particle (Music & Gagnon, 2010). A study demonstrated that viral RNA
synthesis is regulated by the interaction of N-protein and Nsp9 (Liu et al., 2016). Therefore,
pSDFL27 failed to be recovered in the cells, possibly because the assembly of the viral particle
was hindered. The replacement ORF-7 of PRRSV-1 with ORF-7 of PRRSV-2 will result in the
production of N-protein of PRRSV-2 and Nsp9 from the backbone of PRRSV-1. These two
proteins from distinct strains may possess different characteristics, which can impede the
signaling process and RNA synthesis during the assembly. Hence, there was no viral particle
produced in the cells. Furthermore, another study clarifies ORF-7 of PRRSV-2 is conserved
(Meng et al., 1995). This indicates that the nucleocapsid of PRRSV-2 can only assemble with the
viral genome of PRRSV-2, and vice versa (Meng et al., 1995).
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4.7 Conclusion
In conclusion, chimeric pSDFL27 was not able to replicate when transfected into cells,
demonstrating that some proteins within ORF 2-7 play significant roles in viral replication and
assembly. Thus, these cannot be put in a vector from a different strain. N-protein could be one
crucial protein that is not reciprocal between types. Assessment of immune-response induction is
still unclear at this point since the chimeric virus failed to recover. However, these results could
further the knowledge regarding the reverse genetic system designed in this experiment, and they
suggest that the viral vector from the same virus species, but a composite of different strains, also
has limitations in terms of its capability to deliver proteins from viruses with significant genetic
differences.
4.8 List of Figures and Tables
Restriction Sites
PasI (cut in two sites)
PacI
SbfI (new site)
XbaI

Sequences
Cccaggg
Ttaattaa
Cctgcagg
Tctaga

Table 1: displayed significant restriction site with the sequences for plasmid constructs in this
experiment. SbfI (red) is the new insertion site.

Figure 1: pSD01-08 (PRRSV-1) backbone does not have restriction site SbfI. Pm SD01-08
(bottom) was confirmed to have SbfI site.
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Figure 2: full-length modified plasmid
pmSD01-08 with Sbf1 and PacI sites.

Figure 3: showed the gel electrophoresis
results from intermediate 1 and pm SD01-08.
The left band is intermediate 1, having less
base pairs than the right band (pmSD01-08).

Figure 4: Lane 1,3,5 correspond to clone #2 (pmSD01-08)
and lane 2,4,6 correspond to clone #3 (pmSD01-08). Both
clones were digested with several restriction enzymes (SbfI,
EcoRV, AscI) to ensure the presence of new insertion site and
full-genome of PRRSV-1.
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Figure 5: showed GFP expressed cell (A), NCV1 infectious clone (B) as
positive control, pm SD01-08 clone#2 (C), and pm SD01-08 clone#3 (D).
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Figure 7: depicted pSDFL27 is not infectious (fig 7A), GFP expressed
well in cell (fig 7C), and both positive control of NCV1 and pmSD01-08
produced fluorescence (fig 7D)
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